| Title | Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation. | | Author(s) | Saggar R, Shapiro SS, Ross DJ, Fishbein MC, Zisman DA, Lynch JP, Weigt SS, Ardehali A, Belperio JA, Saggar R | | Institution | Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90095-1690, USA. rasaggar@mednet.ucla.edu | | Source | J Heart Lung Transplant 2009 Sep; 28(9):964-7. | | Abstract | The available therapies and prognosis of idiopathic pulmonary fibrosis remain relatively poor, and concurrent pulmonary hypertension further increases the risk of death and complications after lung transplantation. Limited data exist for the treatment of pulmonary hypertension associated with idiopathic pulmonary fibrosis. We describe a case where intravenous treprostinil was used to bridge an elderly patient with idiopathic pulmonary fibrosis with severe pulmonary hypertension to successful single-lung transplantation. | | Language | eng | | Pub Type(s) | Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
| | PubMed ID | 19716051 |
|
